A Randomized Clinical Trial of Histamine 2 Receptor Antagonism in Treatment-Resistant Schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized Clinical Trial of Histamine 2 Receptor Antagonism in Treatment-Resistant Schizophrenia

Published:2013-08 Issue:4 Volume:33 Page:472-478
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Meskanen Katarina,Ekelund Heidi,Laitinen Jarmo,Neuvonen Pertti J.,Haukka Jari,Panula Pertti,Ekelund Jesper

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference31 articles.

1. Recovery from schizophrenia: a concept in search of research.;Liberman;Psychiatr Serv,2005

2. Deficit and nondeficit forms of schizophrenia: the concept.;Carpenter;Am J Psychiatry,1988

3. Psychosis pathways converge via D2 high dopamine receptors.;Seeman;Synapse,2006

4. Emerging drugs for schizophrenia.;Biedermann;Expert Opin Emerg Drugs,2011

5. The role of histamine and the tuberomamillary nucleus in the nervous system.;Haas;Nat Rev Neurosci,2003

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of pharmacological agents for the management of treatment-resistant schizophrenia: a network meta-analysis;Expert Review of Clinical Pharmacology;2024-01-26

2. Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy;Life;2024-01-23

3. Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study;Journal of Psychosomatic Research;2023-09

4. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study;Molecular Psychiatry;2023-04-17

5. Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia;International Journal of Molecular Sciences;2023-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3